Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals

Veterinary Journal

Volumn 174, Issue 2, 2007, Pages 418-421

  Venner, Monica ^a   Kerth, Regina ^a   Klug, Erich ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antibiotic; Foals; Lung abscesses; Treatment; Tulathromycin

Indexed keywords

AZITHROMYCIN; MACROLIDE; RIFAMPICIN; TULATHROMYCIN; UNCLASSIFIED DRUG;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; ECHOGRAPHY; FOAL; INJECTION SITE SWELLING; LUNG ABSCESS; NONHUMAN; OUTCOME ASSESSMENT; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DISACCHARIDES; DRUG THERAPY, COMBINATION; HETEROCYCLIC COMPOUNDS; HORSE DISEASES; HORSES; INJECTIONS, INTRAMUSCULAR; LUNG ABSCESS; RANDOM ALLOCATION; RIFAMPIN; TIME FACTORS; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); BOS; SUIDAE;

EID: 34548767585     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2006.08.016     Document Type: Article

References (10)

1. Benchaoui H.A., Nowakowski M., Sherington J., Rowan T.G., and Sunderland S.J. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 203-210
2. Galer D., Hessong S., Beato B., Risk J., Inskeep P., Weerasinghe C., Schneider R.P., Langer C., Laperle J., Renouf D., Bessire A., Espanol E., Rafka R., Ragan C., Boettner W., Murphy T., Keller D., Benachoui H., and Nowakowski M.A. An analytical method for the analysis of tulathromycin, an equilibrating triamilide, in bovine and porcine plasma and lung. Journal of Agriculture and Food Chemistry 52 (2004) 2179-2191
3. Giguère S., Jacks S., Roberts G.D., Hernandez J., Long M.T., and Ellis C. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi-pneumonia. Journal of Veterinary Internal Medicine 18 (2004) 568-573
4. Gustaffson A., Baverud V., Gunnarson A., Horn T., Rantzien A.F., Lindholm A., and Franklin A. The association of erythromycin ethylsuccinate with acute colitis induction in horses in Sweden. Equine Veterinary Journal 4 (1997) 314-318
5. Jacks S., Giguère S., Gronwall R.R., Brown M.P., Kelly A., and Merritt B.S. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. American Journal of Veterinary Research 62 (2001) 1870-1875
6. Kenney D.G., Robbins S.C., Prescott J.F., Kaushik A., and Baird J.D. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi-pneumonia. Equine Veterinary Journal 25 (1994) 246-248
7. Nowakowski M.A., Inskeep P.B., Risk J.E., Skogerboe T.L., Benchaoui H.A., Meinert T.R., Sherington J., and Sunderland S.J. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Veterinary Therapeutics 5 (2004) 60-74
8. Ohnesorge B., Trötschel C., and Deegen E. Bestimmung von Totraum und exspiratorischem Mischluftvolumen zur Diagnostik chronischer Lungenerkrankungen beim Pferd. Pferdeheilkunde 14 (1998) 450-455
9. Prescott J.F., Machang'u R., Kwiecien J., and Delaney K. Prevention of foal mortality due to Rhodococcus equi-pneumonia on an endemically affected farm. Canadian Veterinary Journal 30 (1989) 871-875
10. Stratton-Phelbs M., Wilson W.D., and Gardner I.A. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). Journal of the American Veterinary Medical Association 217 (2000) 68-73